ZA200003235B - Combination therapy for the treatment of migraine. - Google Patents

Combination therapy for the treatment of migraine.

Info

Publication number: ZA200003235B
Authority: ZA; South Africa
Prior art keywords: migraine; treatment; combination therapy; therapy; combination
Prior art date: 1999-06-30

Application number

ZA200003235A

Other languages

English (en)

Inventor

Wilma Marcia Harrison

George Harry Sands

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-06-30

Filing date

2000-06-28

Publication date

2002-01-02

2000-06-28 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2002-01-02 Publication of ZA200003235B publication Critical patent/ZA200003235B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200003235A 1999-06-30 2000-06-28 Combination therapy for the treatment of migraine. ZA200003235B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US14168099P	1999-06-30	1999-06-30

Publications (1)

Publication Number	Publication Date
ZA200003235B true ZA200003235B (en)	2002-01-02

Family

ID=22496730

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200003235A ZA200003235B (en)	1999-06-30	2000-06-28	Combination therapy for the treatment of migraine.

Country Status (11)

Country	Link
US (1)	US20030216458A1 (xx)
EP (1)	EP1064948A3 (xx)
JP (1)	JP2001031568A (xx)
KR (1)	KR20010066886A (xx)
AU (1)	AU4271100A (xx)
CA (1)	CA2312633A1 (xx)
CO (1)	CO5190678A1 (xx)
HU (1)	HUP0002508A3 (xx)
IL (1)	IL136962A0 (xx)
PE (1)	PE20010513A1 (xx)
ZA (1)	ZA200003235B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8022095B2 (en)	1996-08-16	2011-09-20	Pozen, Inc.	Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
CA2415697A1 (en) *	2000-07-13	2002-01-24	James C. Forbes	Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain
WO2002017896A2 (en) *	2000-08-29	2002-03-07	Peter Van Patten	Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
WO2004060355A1 (en)	2002-12-26	2004-07-22	Pozen Inc.	Multilayer Dosage Forms Containing NSAIDs and Triptans
NL2000351C2 (nl)	2005-12-22	2007-09-11	Pfizer Prod Inc	Estrogeen-modulatoren.
US8618157B2 (en)	2008-06-20	2013-12-31	Alphapharm Pty. Ltd.	Pharmaceutical formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5466823A (en) *	1993-11-30	1995-11-14	G.D. Searle & Co.	Substituted pyrazolyl benzenesulfonamides
US5872145A (en) *	1996-08-16	1999-02-16	Pozen, Inc.	Formulation of 5-HT agonist and NSAID for treatment of migraine
US5891885A (en) *	1996-10-09	1999-04-06	Algos Pharmaceutical Corporation	Method for treating migraine
AU724728B2 (en) *	1997-07-03	2000-09-28	Pfizer Inc.	Pharmaceutical compositions containing eletriptan hemisulphate and caffeine

2000
- 2000-06-16 CO CO00045172A patent/CO5190678A1/es unknown
- 2000-06-22 IL IL13696200A patent/IL136962A0/xx unknown
- 2000-06-26 EP EP00305352A patent/EP1064948A3/en not_active Withdrawn
- 2000-06-26 PE PE2000000638A patent/PE20010513A1/es not_active Application Discontinuation
- 2000-06-27 AU AU42711/00A patent/AU4271100A/en not_active Abandoned
- 2000-06-28 ZA ZA200003235A patent/ZA200003235B/xx unknown
- 2000-06-28 CA CA002312633A patent/CA2312633A1/en not_active Abandoned
- 2000-06-29 HU HU0002508A patent/HUP0002508A3/hu unknown
- 2000-06-30 JP JP2000197648A patent/JP2001031568A/ja active Pending
- 2000-06-30 KR KR1020000036795A patent/KR20010066886A/ko not_active Ceased
2003
- 2003-04-09 US US10/410,664 patent/US20030216458A1/en not_active Abandoned

Also Published As

Publication number	Publication date
EP1064948A2 (en)	2001-01-03
PE20010513A1 (es)	2001-04-21
EP1064948A3 (en)	2003-01-08
KR20010066886A (ko)	2001-07-11
CO5190678A1 (es)	2002-08-29
AU4271100A (en)	2001-01-04
IL136962A0 (en)	2001-06-14
HUP0002508A3 (en)	2001-07-30
CA2312633A1 (en)	2000-12-30
US20030216458A1 (en)	2003-11-20
JP2001031568A (ja)	2001-02-06
HUP0002508A2 (hu)	2001-05-28
HU0002508D0 (en)	2000-08-28

Publication	Publication Date	Title
AU2002350235A1 (en)	2003-06-10	Combination bacteriolytic therapy for the treatment of tumors
IL196301A0 (en)	2009-09-22	Medicament for the treatment of hapatitis c
ZA200109335B (en)	2003-01-29	Generation of therapeutic microfoam.
IL158329A0 (en)	2004-05-12	Antiangiogenic combination therapy for the treatment of cancer
HUP0500424A2 (en)	2007-02-28	Combination therapy for the treatment of cancer
IL146697A0 (en)	2002-07-25	SELECTIVE iGluR5 RECEPTOR FOR THE TREATMENT OF MIGRAINE
ZA200003236B (en)	2002-01-02	Combination therapy for the treatment of migraine.
ZA200202822B (en)	2003-09-23	Oncolytic combinations for the treatment of cancer.
ZA200110436B (en)	2004-03-31	Therapeutic use of melatonin.
IL162818A0 (en)	2005-11-20	Combination therapy for the treatment of bacterialinfections
HUP0101947A3 (en)	2001-12-28	Combination for the treatment of tumors
AU2001285156A1 (en)	2002-03-04	Combination therapy for the treatment of migraine
ZA200002338B (en)	2001-11-12	Combination therapy for the treatment of migraine.
ZA200003235B (en)	2002-01-02	Combination therapy for the treatment of migraine.
ZA200002343B (en)	2001-11-12	Combination therapy for the treatment of migraine.
ZA200110539B (en)	2003-03-24	Oxazinocarbazoles for the treatment of CNS diseases.
ZA200203166B (en)	2003-06-25	Treatment of cancer.
ZA200110046B (en)	2003-03-06	Therapeutic agents.
HUP0100365A3 (en)	2002-06-28	Combination therapy for the treatment of aids
ZA991786B (en)	1999-09-06	Therapeutic treatment for asthma.
PL371270A1 (en)	2005-06-13	Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
ZA200408071B (en)	2005-10-18	Combination therapy for the treatment of cancer.
GB9807938D0 (en)	1998-06-10	Combination therapy for the treatment of AIDS
GB9819590D0 (en)	1998-11-04	Combination therapy for the treatment of aids
GB9918785D0 (en)	1999-10-13	Therapeutic treatment